Announcements

December 1, 2014 - Edison Nation Medical, the premier marketplace for healthcare and medical device innovation, today announced a partnership with the Mount Sinai Health System, one of the country's largest integrated health care networks providing exceptional medical care and world-class medical research. Edison Nation Medical will work closely with ...

November 13, 2014 - The Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai is conducting an investigational pilot study of a respiratory disease management platform, developed by Cohero Health, in pediatric asthma patients seen in two high volume pediatric clinics at the ...

Novo Nordisk is inviting a limited number of leading US academic and medical research institutions to announce this opportunity among those faculty members who could potentially have novel ideas for biologics innovation within diabetes and obesity research. These Awards can be granted to faculty members who enter this competitive ...

Mount Sinai Innovation Partners, MSIP, is actively searching for qualified candidates for a number of open positions. To learn more about the opportunities and becoming a part of the Mount Sinai community, click on the links below. Business Development Director Business Development Manager Sr. Contracts & Commercial ...

Neurotrope enters into world-wide, exclusive license agreement with Mount Sinai; Files related provisional patent for Bryostatin-1   July 22, 2014 - Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. (otcqb:NTRP) has signed a world-wide, exclusive license agreement with the Icahn School of Medicine at Mount Sinai (Mount Sinai) to utilize its proprietary ...

For better or for worse, we’re living in an era of near constant self-quantification. From wi-fi enabled bathroom scales, to activity monitoring wristbands, to personal DNA sequencing, consumers are gathering more data about their health and wellness than at any time in history. Add to this existing data sources like ...

SPRING HOUSE, Pa., May 5, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the establishment of a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC), Prometheus Laboratories Inc. (Prometheus), Mayo Clinic, Rochester, Minnesota (Mayo Clinic), Centre Hospitalier Regional Universitaire (CHRU) de Lille, France (Lille) and the Icahn School of ...

May 2, 2014 - Auven Therapeutics, the global private equity company focused on accelerated development of breakthrough therapeutic drugs and BELLUS Health Inc. (TSX: BLU), a drug development company focused on rare diseases, today announced that Auven has entered into a license agreement with the Icahn School of Medicine at ...

by AvalancheInfographics. Explore more visuals like this one on the web's largest information design community - Visually.

April 8, 2014 - A research team from the Icahn School of Medicine at Mount Sinai published the first controlled evidence showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect –within 24 hours—and was well tolerated in patients with treatment-resistant major depressive disorder. This is the first study ...